Gara Jalqabaatti › Obesity
Qorannoo klinikaalii Obesity Ameerikaa Keessatti hirmaatuu
Qorannoo 480 Obesity f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 43
- Chicago, ILQorannoo 41
- New York City, NYQorannoo 40
- San Antonio, TXQorannoo 40
- Washington, DCQorannoo 33
- Orlando, FLQorannoo 32
- Dallas, TXQorannoo 30
- Boston, MAQorannoo 28
- Las Vegas, NVQorannoo 27
- Miami, FLQorannoo 27
- Baltimore, MDQorannoo 26
- Jacksonville, FLQorannoo 25
- St. Louis, MOQorannoo 25
- Atlanta, GAQorannoo 24
- Los Angeles, CAQorannoo 23
- San Diego, CAQorannoo 23
- Birmingham, ALQorannoo 23
- Philadelphia, PAQorannoo 23
- Phoenix, AZQorannoo 22
- Aurora, COQorannoo 22
- Indianapolis, INQorannoo 20
- Durham, NCQorannoo 20
- Austin, TXQorannoo 20
- Cincinnati, OHQorannoo 19
- Salt Lake City, UTQorannoo 18
- Arlington, VAQorannoo 18
- Concord, CAQorannoo 18
- Tucson, AZQorannoo 18
- Louisville, KYQorannoo 17
- Havelock, NCQorannoo 17
- Nashville, TNQorannoo 17
- Johns Creek, GAQorannoo 16
- Charlotte, NCQorannoo 16
- Baton Rouge, LAQorannoo 15
- Wilmington, NCQorannoo 15
- Columbus, OHQorannoo 15
- Rochester, NYQorannoo 14
- Providence, RIQorannoo 14
- Pittsburgh, PAQorannoo 13
- Honolulu, HIQorannoo 13
Naannoon
- AlabamaQorannoo 40
- ArizonaQorannoo 41
- ArkansasQorannoo 13
- CaliforniaQorannoo 99
- ColoradoQorannoo 26
- ConnecticutQorannoo 22
- Distaarikii KoloombiyaaQorannoo 12
- FloridaQorannoo 74
- GeorgiaQorannoo 44
- HawaiiQorannoo 13
- IdahoQorannoo 21
- IllinoisQorannoo 57
- IndianaQorannoo 25
- IowaQorannoo 9
- KansasQorannoo 32
- KentuckyQorannoo 27
- LouisianaQorannoo 33
- MaineQorannoo 3
- MarylandQorannoo 54
- MassachusettsQorannoo 44
- MichiganQorannoo 29
- MinnesotaQorannoo 29
- MississippiQorannoo 15
- MissouriQorannoo 54
- MontanaQorannoo 9
- NebraskaQorannoo 10
- NevadaQorannoo 29
- New HampshireQorannoo 3
- New JerseyQorannoo 20
- New MexicoQorannoo 7
- New YorkQorannoo 75
- North CarolinaQorannoo 60
- North DakotaQorannoo 8
- OhioQorannoo 46
- OklahomaQorannoo 21
- OregonQorannoo 18
- PennsylvaniaQorannoo 48
- Rhode IslandQorannoo 19
- South CarolinaQorannoo 45
- South DakotaQorannoo 6
- TennesseeQorannoo 38
- TexasQorannoo 81
- UtahQorannoo 29
- VirginiaQorannoo 43
- WashingtonQorannoo 31
- West VirginiaQorannoo 4
- WisconsinQorannoo 11
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05216042Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05726942The RESET System Pivotal Clinical Trial (Protocol Revision H)
Namoota walitti qabaa jira
Umuriin 22 hanga 65 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04101669A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 69 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07789769Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06627569Efficacy of Using Mobile Health Applications for Health
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05589155Tirzepatide in Obesity-Driven Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Dubartoota · Haaromfame 02-Onk-2026 · NCT07065552Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979New Heart Imaging Techniques to Evaluate Possible Heart Disease
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01399385Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 21 hanga 75 · Dubartoota · Haaromfame 02-Onk-2026 · NCT03288207Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05279729Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamooKaffaltii hirmaatootaaf ibsa
Umuriin 19 hanga 85 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01927783A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07675590Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity
Namoota walitti qabaa jira
Umuriin 18 hanga 35 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07853898Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 1 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01143454Level Up! (The Combined and Independent Effects of Exercise Training and Dietary Enhancement on Cardiometabolic Health in Adolescents With Obesity)
Namoota walitti qabaa jira
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06848478Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Namoota walitti qabaa jira
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07641361Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Namoota walitti qabaa jira
Umuriin 21 hanga 65 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07090005Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07582016A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07793929A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07783802Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.